Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations

PURPOSE: We investigated the effect on outcome of measurable or minimal residual disease (MRD) status after each induction course to evaluate the extent of its predictive value for acute myeloid leukemia (AML) risk groups, including NPM1 wild-type (wt) standard risk, when incorporated with other ind...

Full description

Saved in:
Bibliographic Details
Published in:J Clin Oncol
Main Authors: Freeman, Sylvie D., Hills, Robert K., Virgo, Paul, Khan, Naeem, Couzens, Steve, Dillon, Richard, Gilkes, Amanda, Upton, Laura, Nielsen, Ove Juul, Cavenagh, James D., Jones, Gail, Khwaja, Asim, Cahalin, Paul, Thomas, Ian, Grimwade, David, Burnett, Alan K., Russell, Nigel H.
Format: Artigo
Language:Inglês
Published: American Society of Clinical Oncology 2018
Subjects:
ORIGINAL REPORTS
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5959196/
https://ncbi.nlm.nih.gov/pubmed/29601212
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.76.3425
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items